PT1773361E - Composição baseada em bactérias probióticas e sua utilização na prevenção e/ou tratamento de patologias e/ou infecções respiratórias e na melhoria da funcionalidade intestinal - Google Patents

Composição baseada em bactérias probióticas e sua utilização na prevenção e/ou tratamento de patologias e/ou infecções respiratórias e na melhoria da funcionalidade intestinal Download PDF

Info

Publication number
PT1773361E
PT1773361E PT05793656T PT05793656T PT1773361E PT 1773361 E PT1773361 E PT 1773361E PT 05793656 T PT05793656 T PT 05793656T PT 05793656 T PT05793656 T PT 05793656T PT 1773361 E PT1773361 E PT 1773361E
Authority
PT
Portugal
Prior art keywords
based composition
probiotic bacteria
infections
prevention
improvement
Prior art date
Application number
PT05793656T
Other languages
English (en)
Inventor
Giovanni Mogna
Gian Paolo Strozzi
Original Assignee
Probiotical Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35677517&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1773361(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Probiotical Spa filed Critical Probiotical Spa
Publication of PT1773361E publication Critical patent/PT1773361E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PT05793656T 2004-11-16 2005-10-05 Composição baseada em bactérias probióticas e sua utilização na prevenção e/ou tratamento de patologias e/ou infecções respiratórias e na melhoria da funcionalidade intestinal PT1773361E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT002189A ITMI20042189A1 (it) 2004-11-16 2004-11-16 Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale

Publications (1)

Publication Number Publication Date
PT1773361E true PT1773361E (pt) 2009-10-22

Family

ID=35677517

Family Applications (1)

Application Number Title Priority Date Filing Date
PT05793656T PT1773361E (pt) 2004-11-16 2005-10-05 Composição baseada em bactérias probióticas e sua utilização na prevenção e/ou tratamento de patologias e/ou infecções respiratórias e na melhoria da funcionalidade intestinal

Country Status (15)

Country Link
US (1) US9233130B2 (pt)
EP (1) EP1773361B2 (pt)
JP (1) JP2008520640A (pt)
KR (1) KR101228608B1 (pt)
CN (1) CN101031313B (pt)
BR (1) BRPI0517273B8 (pt)
DE (1) DE602005015451D1 (pt)
DK (1) DK1773361T4 (pt)
ES (1) ES2329390T5 (pt)
HK (1) HK1110510A1 (pt)
IT (1) ITMI20042189A1 (pt)
PL (1) PL1773361T5 (pt)
PT (1) PT1773361E (pt)
RU (1) RU2418063C2 (pt)
WO (1) WO2006054135A1 (pt)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20042189A1 (it) 2004-11-16 2005-02-16 Anidral Srl Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale
EP1973406B1 (en) 2005-12-28 2014-03-12 Advanced Bionutrition Corporation A delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form
JP5896589B2 (ja) * 2006-10-02 2016-03-30 デュポン ニュートリション バイオサイエンシーズ エーピーエス 疾病の罹患率及び持続期間を減少する使用のためのプロバイオティクス
WO2008071930A1 (en) * 2006-12-11 2008-06-19 Danisco A/S Composition
CA2695366C (en) 2007-08-03 2016-10-04 Shaklee Corporation Nutritional supplement system
US9763989B2 (en) 2007-08-03 2017-09-19 Shaklee Corporation Nutritional supplement system
WO2009021585A1 (en) * 2007-08-13 2009-02-19 Dsm Ip Assets B.V. Probiotic bacteria for rducing the occurence of symptoms of winter infections
US9055763B2 (en) * 2007-10-11 2015-06-16 Dupont Nutrition Biosciences Aps Probiotics for use in relieving symptoms associated with gastronitestinal disorders
ITMI20072260A1 (it) 2007-12-03 2009-06-04 Anidral Srl Una composizione a base di batteri probiotici in associazione con un prebiotico e suo uso nella prevenzione e/o nel trattamento di patologie e/o infezioni respiratorie e nel miglioramento della funzionalita intestinale.
US20090280099A1 (en) * 2008-05-07 2009-11-12 Bachman Stephen E Nasopharyngeal inoculate of probiotics and prebiotics for treatment of respiratory infections
JP5426850B2 (ja) * 2008-08-19 2014-02-26 株式会社日清製粉グループ本社 インフルエンザワクチンのアジュバント
KR101001767B1 (ko) 2008-11-04 2010-12-15 주식회사한국야쿠르트 항 인플루엔자 바이러스 효능을 갖는 락토바실러스 루테리 에이취와이7501 및 이를 유효성분으로 함유하는 제품
RU2011124506A (ru) 2008-11-17 2012-12-27 Эссум Аб Фармацевтический препарат, содержащий комбинацию штаммов streptococcus и штаммов lactobacillus
WO2010103132A1 (es) * 2009-03-10 2010-09-16 Hero España, S.A. Aislamiento, identificación y caracterización de cepas con actividad probiótica a partir de heces de lactantes alimentados exclusivamente con leche materna
ES2643148T3 (es) 2009-05-26 2017-11-21 Advanced Bionutrition Corporation Composición en polvo seco estable que comprende microorganismos biológicamente activos y/o materiales bioactivos y métodos de producción
IT1397566B1 (it) * 2009-05-27 2013-01-16 Probiotical Spa Lactobacillus pentosus produttore di batteriocine, composizioni alimentari e farmaceutiche contenenti lo stesso e relativo uso
WO2011044934A1 (en) * 2009-10-14 2011-04-21 Probiotical S.P.A Probiotic bacteria strains enabling of hydrolyzing prebiotic fibers and symbiotic compositions thereof
US20110123677A1 (en) * 2009-11-25 2011-05-26 Pepsico, Inc. High acid beverage products and methods to extend probiotic stability
FI20096400A0 (fi) * 2009-12-28 2009-12-28 Suomen Punainen Risti Veripalv Veriryhmästatuksen käyttö I
AR080073A1 (es) 2010-01-28 2012-03-14 Advanced Bionutrition Corp Composicion vitrea seca que comprende un material bioactivo
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
IT1398553B1 (it) * 2010-03-08 2013-03-01 Probiotical Spa Composizione comprendente batteri probiotici per il trattamento di patologie associate con le alterazioni del sistema immunitario.
WO2011148219A1 (en) * 2010-05-28 2011-12-01 Compagnie Gervais Danone Probiotic strains for use in improving the enteric nervous system
CL2010001124A1 (es) * 2010-10-14 2011-01-21 Univ De Concepcion 50% Ma Loreto Ormeno 50% Alimento funcional probiotico que comprende cepas viables de lactobacillus sp.; uso de dicho alimento funcional para contrarestar los efectos colaterales de la quimioterapia.
GB201110095D0 (en) * 2011-06-15 2011-07-27 Danisco Method of treatment
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
ITRM20110475A1 (it) * 2011-09-09 2013-03-10 Probiotical Spa Ceppi di batteri lattici e/o bifido batteri, opzionalmente addizionati di n-acetilcisteina e/o lisozima microincapsulato gastroprotetto, aventi attivita' di inibizione/riduzione della crescita di differenti biotipi di e.coli, incluso e.coli o157:h7 e
ITRM20110477A1 (it) * 2011-09-09 2013-03-10 Giovanni Mogna Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
EP2802333B1 (en) * 2012-01-13 2020-03-11 Chr. Hansen A/S Lactobacillus rhamnosus and bifidobacterium animalis subsp. lactis for use in prevention or treatment of upper respiratory tract infections
KR101381794B1 (ko) * 2012-04-10 2014-04-07 씨제이제일제당 (주) 타가토스 및 프로바이오틱 유산균을 함유하는 신바이오틱 식품 조성물
KR101398977B1 (ko) * 2012-11-14 2014-05-27 대구가톨릭대학교산학협력단 락토바실러스 카세이 유산균주 배양용 d-타가토오스 함유 배지 및 d-타가토오스첨가 요구르트의 제조방법
JP6349095B2 (ja) * 2013-01-31 2018-06-27 ハイスキー食品工業株式会社 こんにゃく素材および希少糖の組み合わせ食品
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
CN103798392B (zh) * 2014-03-07 2015-12-30 内蒙古伊利实业集团股份有限公司 具有缓解咽喉部炎症功效的益生菌食品组合物及食品
HUE037476T2 (hu) 2014-12-23 2018-08-28 4D Pharma Res Ltd Pirin polipeptid és immunmodulálás
JP6271093B1 (ja) 2014-12-23 2018-01-31 フォーディー ファーマ リサーチ リミテッド４Ｄ Ｐｈａｒｍａ Ｒｅｓｅａｒｃｈ Ｌｉｍｉｔｅｄ 免疫調節
BR112017026564B1 (pt) 2015-06-15 2022-05-03 4D Pharma Research Limited Células de bactéria, usos das mesmas, e composição
CN107847529B (zh) 2015-06-15 2022-05-03 4D制药研究有限公司 包含细菌菌株的组合物
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
CN108271354B (zh) 2015-06-15 2022-07-29 4D制药研究有限公司 包含细菌菌株的组合物
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
CN105055438A (zh) * 2015-07-21 2015-11-18 珲春市神怡菌业生物科技开发有限公司 一种具有改善胃肠道功能的香菇多糖益生元组合物
MY194231A (en) 2015-07-29 2022-11-23 Advanced Bionutrition Corp Stable dry probiotic compositions for special dietary uses
ITUB20153106A1 (it) * 2015-08-13 2017-02-13 Probiotical Spa Composizione di batteri lattici per uso nel trattamento delle infezioni causate da Propionibacterium acnes e in particolare per l'acne
MA45287A (fr) 2015-11-20 2018-08-22 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
ITUB20159330A1 (it) 2015-12-22 2017-06-22 Roelmi Hpc S R L Composizioni probiotiche e loro uso
KR101749222B1 (ko) * 2016-01-04 2017-06-21 주식회사 카브 젖산균을 유효성분으로 포함하는 인플루엔자 바이러스 예방 및 치료용 조성물
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
JP6441536B2 (ja) 2016-03-04 2018-12-19 フォーディー ファーマ ピーエルシー４Ｄ Ｐｈａｒｍａ Ｐｌｃ 細菌株を含む組成物
TW201821093A (zh) 2016-07-13 2018-06-16 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
CN106177188A (zh) * 2016-08-02 2016-12-07 马南行 一种用于女性抑菌平衡的益生菌组合物及其制备方法
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
US11179426B2 (en) * 2016-12-29 2021-11-23 Kibow Biotech, Inc. Composition and method for maintaining healthy kidney function
CA3064171A1 (en) 2017-05-22 2018-11-29 4D Pharma Research Limited Compositions comprising bacterial strains
TW201907931A (zh) 2017-05-24 2019-03-01 英商4D製藥研究有限公司 包含細菌菌株之組合物
DK3600364T3 (da) 2017-06-14 2020-08-31 4D Pharma Res Ltd Sammensætninger omfattende en bakteriestamme af slægten megasphaera og anvendelser deraf
HUE052319T2 (hu) 2017-06-14 2021-04-28 4D Pharma Res Ltd Baktériumtörzseket tartalmazó készítmények
CN108295098A (zh) * 2018-02-02 2018-07-20 云南中京国建投资有限公司 一种辅助降血糖的合生元组合物及其制剂与应用
WO2019227414A1 (zh) * 2018-05-31 2019-12-05 深圳华大生命科学研究院 一种组合物及其应用
KR101932955B1 (ko) 2018-06-14 2018-12-27 주식회사한국야쿠르트 장내 균총 개선용 프로바이오틱스 조성물
TW202015712A (zh) * 2018-07-03 2020-05-01 學校法人北里研究所 用以抑制流感之重症化的抗流感病毒劑
CN109432136A (zh) * 2018-10-31 2019-03-08 张志澎 一种益生菌组合制剂及其制备方法和应用
CN110055185B (zh) * 2018-12-25 2020-12-29 江南大学 一株具有抗流感能力的短双歧杆菌及其应用
CN109576185B (zh) 2018-12-26 2020-07-03 江南大学 一种具有抗流感能力的益生菌混合制剂及其应用
CN111544456A (zh) * 2019-05-15 2020-08-18 农绍汉 一种益生菌配方及其应用
CN110051702A (zh) * 2019-06-06 2019-07-26 广东才俊创展商务服务有限公司 一种防治手足口病、流感的益生菌配方
KR102328744B1 (ko) * 2019-10-08 2021-11-22 한국식품연구원 락토바실러스 플란타럼 균주를 유효성분으로 포함하는 호흡기 질환 개선용 조성물
CN110946990B (zh) * 2019-12-16 2023-05-23 天津瑞普生物技术股份有限公司 一种禽用呼吸道微生态喷雾制剂及其应用
CN111529703B (zh) * 2020-06-17 2023-09-15 湖南循天然营养有限公司 一种组合物及其制备方法与在制备免疫佐剂中的应用
CN112056399A (zh) * 2020-06-28 2020-12-11 武汉康复得生物科技股份有限公司 一种增强免疫力的益生菌组合物及其应用
WO2022103321A2 (en) * 2020-11-12 2022-05-19 Synbiotics Ab Synbiotic composition
TW202302128A (zh) * 2021-03-26 2023-01-16 香港中文大學 微生物提高疫苗效力的用途
CN114657100B (zh) * 2022-04-01 2023-07-25 江南大学 一株能够缓解流感病毒感染小鼠病理特征的戊糖乳杆菌及其应用
CN115025132B (zh) * 2022-06-09 2024-01-30 康永波 一种合生元组合物及其制备方法和应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6241983B1 (en) 1994-10-28 2001-06-05 Metagenics, Inc. Bacteria-and fiber-containing composition for human gastrointestinal health
AUPN881396A0 (en) † 1996-03-20 1996-04-18 Arnott's Biscuits Limited Enhancement of microbial colonization of the gastrointestinal tract
JP4064481B2 (ja) 1996-10-11 2008-03-19 ハウスウェルネスフーズ株式会社 免疫賦活剤
US6379663B1 (en) * 1997-08-21 2002-04-30 New Zealand Dairy Board Immunity enhancing lactic acid bacteria
EP0904784A1 (en) † 1997-09-22 1999-03-31 N.V. Nutricia Probiotic nutritional preparation
NL1010770C2 (nl) † 1998-12-09 2000-06-13 Nutricia Nv Preparaat dat oligosacchariden en probiotica bevat.
WO2001097821A1 (en) * 2000-06-19 2001-12-27 Mucoprotec Pty Ltd Immunotherapy or treating bacterial or viral infection at mucosal surfaces with probiotics, and compositions therefor.
FI110668B (fi) * 2000-06-20 2003-03-14 Aboatech Ab Oy Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn
GB2369777B (en) 2000-10-05 2004-10-27 St Ivel Ltd Food products with antimicrobial lactic acid bacteria
FI109602B (fi) * 2001-01-25 2002-09-13 Valio Oy Probioottiyhdistelmä
DE20202562U1 (de) 2002-02-19 2002-05-23 Orthomol Pharmazeutische Vertr Mikronährstoffkombinationsprodukt mit Pro- und Prebiotika
ITMI20020399A1 (it) * 2002-02-28 2003-08-28 Ct Sperimentale Del Latte S P Composizioni dietetiche e/o farmaceutiche per uso umano e/o animale abase di preparati microbici probiotici
US20050074442A1 (en) 2002-03-13 2005-04-07 Natarajan Ranganathan Compositions and methods for augmenting kidney function
EP2336294A3 (en) 2002-07-22 2014-07-02 Agtech Products, Inc. Lactobacillus strains and uses therefor
BRPI0418986A (pt) 2004-08-05 2007-12-11 Anidral Srl cepas bacterianas bifidobacterium produtoras de ácido fólico, formulações e seus usos
ITMI20042189A1 (it) 2004-11-16 2005-02-16 Anidral Srl Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale
WO2007125558A1 (en) 2006-05-03 2007-11-08 Anidral S.R.L. Symbiotic composition comprising non-digestible polysaccharides and bifidobacteria which metabolize them and its uses
ITMI20072260A1 (it) 2007-12-03 2009-06-04 Anidral Srl Una composizione a base di batteri probiotici in associazione con un prebiotico e suo uso nella prevenzione e/o nel trattamento di patologie e/o infezioni respiratorie e nel miglioramento della funzionalita intestinale.

Also Published As

Publication number Publication date
EP1773361A1 (en) 2007-04-18
ES2329390T5 (es) 2013-02-11
DE602005015451D1 (de) 2009-08-27
PL1773361T3 (pl) 2010-05-31
ES2329390T3 (es) 2009-11-25
PL1773361T5 (pl) 2012-12-31
KR101228608B1 (ko) 2013-02-01
DK1773361T3 (da) 2009-11-16
BRPI0517273A (pt) 2008-10-07
US9233130B2 (en) 2016-01-12
DK1773361T4 (da) 2012-10-15
RU2418063C2 (ru) 2011-05-10
EP1773361B2 (en) 2012-09-26
US20080107634A1 (en) 2008-05-08
BRPI0517273B8 (pt) 2021-05-25
JP2008520640A (ja) 2008-06-19
ITMI20042189A1 (it) 2005-02-16
CN101031313A (zh) 2007-09-05
WO2006054135A1 (en) 2006-05-26
EP1773361B1 (en) 2009-07-15
KR20070089130A (ko) 2007-08-30
BRPI0517273B1 (pt) 2020-11-03
RU2007106038A (ru) 2008-10-27
CN101031313B (zh) 2010-06-16
HK1110510A1 (en) 2008-07-18

Similar Documents

Publication Publication Date Title
HK1110510A1 (en) Probiotic bacteria based composition and use thereof in the prevention and/or treatment of respiratory pathologies and/or infections and in the improvement of the intestinal functionality
ZA200807879B (en) Use of bifidobacterium longum for the prevention and treatment of inflammation
IN2012DN01638A (pt)
PL1981516T3 (pl) Zastosowanie mikroorganizmów probiotycznych w leczeniu i zapobieganiu otyłości i pokrewnym zaburzeniom
UA100551C2 (en) Synbiotic mixture
RS54707B1 (en) TREATMENT OF CROWN LAKVINIMOD DISEASE
PL2219658T3 (pl) Kompozycja oparta na bakteriach probiotycznych w połączeniu z prebiotykiem i jej zastosowanie w zapobieganiu i/lub leczeniu schorzeń oddechowych i/lub infekcji oraz do polepszenia funkcjonalności jelit
GB2467670A (en) Chemical entities and therapeutic uses thereof
MX2023008408A (es) Composiciones antisentido, y metodos para obtener y usar las mismas.
WO2008016643A3 (en) Certain chemical entities, compositions, and methods
MX348797B (es) Microorganismos probioticos como agentes activos para mejorar el brillo de la tez de la piel.
PL2753343T3 (pl) Kompozycja zawierająca n-acetylocysteinę oraz bakterie probiotyczne zdolne do przywrócenia własnego działania barierowego żołądka, które zostaje zniszczone podczas leczenia nadkwaśności soku żołądkowego inhibitorami pompy protonowej
MX2009011127A (es) Metodo de prevencion y tratamiento de angiopatia amiloide cerebral.
EA200701820A1 (ru) Применение диосметиновых соединений при лечении и профилактике тромботических патологий
MY147247A (en) Organic compounds and their uses
MY155299A (en) Oral dosage composition
MX2010001692A (es) Ciertas entidades quimicas, composiciones y metodos.
WO2009040445A3 (en) Arabinoxylo-oligosaccharides useful against gastrointestinal infections
NO20085051L (no) Behandling av gastrointestinale forstyrrelser med CGRP-antagonister
ATE464045T1 (de) Zusammensetzung aus milchsäure und lactoferrin
EP3318251A3 (en) Composition for preventing or treating obesity or lipid-related metabolic disease
WO2007081486A3 (en) Oral administration of defensins to treat intestinal diseases
TNSN08385A1 (en) Delayed-release glucocorticoid treatment of rheumatoid disease
EP2231148A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PREVENTION OF CARDIAC DISEASE
EP2010215A4 (en) METHOD AND COMPOSITIONS FOR TREATING MORBUS CROHN